PMC:7571312 / 9585-9854 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T46","span":{"begin":260,"end":268},"obj":"Disease"}],"attributes":[{"id":"A46","pred":"mondo_id","subj":"T46","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T86009","span":{"begin":209,"end":210},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T118","span":{"begin":231,"end":233},"obj":"Chemical"}],"attributes":[{"id":"A118","pred":"chebi_id","subj":"T118","obj":"http://purl.obolibrary.org/obo/CHEBI_74327"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T6","span":{"begin":55,"end":72},"obj":"http://purl.obolibrary.org/obo/GO_0019079"},{"id":"T7","span":{"begin":55,"end":72},"obj":"http://purl.obolibrary.org/obo/GO_0019058"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}

{"project":"LitCovid-sentences","denotations":[{"id":"T47","span":{"begin":0,"end":269},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}

{"project":"LitCovid-PubTator","denotations":[{"id":"242","span":{"begin":84,"end":97},"obj":"Species"},{"id":"252","span":{"begin":260,"end":268},"obj":"Disease"}],"attributes":[{"id":"A242","pred":"tao:has_database_id","subj":"242","obj":"Tax:11118"},{"id":"A252","pred":"tao:has_database_id","subj":"252","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"In addition to the potent inhibition of the 3CLpro and viral replication of several coronaviruses, 4 possesses solubility as well as metabolic and chemical stability characteristics, which are consistent with a continuous infusion IV therapeutic treatment for COVID-19."}